Adjuvant Taxanes in the Treatment of Breast Cancer: No Longer at the Tip of the Iceberg

This publication has 16 references indexed in Scilit:

• Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
  Annals of Oncology, 2005
• Adjuvant Docetaxel for Node-Positive Breast Cancer
  New England Journal of Medicine, 2005
• Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28
  Journal of Clinical Oncology, 2005
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  The Lancet, 2005
• Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
  Journal of Clinical Oncology, 2003
• Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
  Journal of Clinical Oncology, 2003
• Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial
  Journal of Clinical Oncology, 2003
• National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000
  JNCI Journal of the National Cancer Institute, 2001
• Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial
  Journal of Clinical Oncology, 2001
• Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update
  Cancer, 1983